✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Legend Biotech Corp

Common Name
Legend Biotech
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,600
Ticker
LEGN
Exchange
NASDAQ/NGS
Description
Legend Biotech Corporation develops, manufactures, and commercializes chimeric antigen receptor T-cell (CAR-T) therapies for oncology and other serious diseases. The company's flagship product is CARV...

Disclosures of Legend Biotech

Explore Legend Biotech's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Legend Biotech's official channels and fully traceable to its official company sources.

The table below lists all of Legend Biotech's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20253 disclosures
20-F
en
Financial & Extra-Financial Disclosure
en
Financial Report
en
20242 disclosures
ESG Report
en
20-F
en
20232 disclosures
ESG Report
en
20-F
en
20221 disclosure
Financial & Extra-Financial Disclosure
en
20212 disclosures
20-F
Financial & Extra-Financial Disclosure
20202 disclosures
20-F
Financial & Extra-Financial Disclosure
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?